Effects of the non-competitive NMDA receptor antagonist ifenprodil on the morphine-induced place preference in mice

Life Sciences

Volumn 64, Issue 12, 1999, Pages PL151-PL156

  Suzuki, Tsutomu ^a   Kato, Hideaki ^a   Tsuda, Makoto ^a   Suzuki, Hajime ^a,b   Misawa, Miwa ^a  

^a HOSHI UNIVERSITY   (Japan)

^b Grelan Pharmaceutical Co Ltd   (Japan)

Author keywords

Conditioned place preference; Ifenprodil; Morphine; NMDA

Indexed keywords

DIZOCILPINE; DOPAMINE; IFENPRODIL; KETAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; RECEPTOR SUBUNIT;

ANIMAL MODEL; ARTICLE; AVERSION; BINDING AFFINITY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG RECEPTOR BINDING; HYPERKINESIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MOUSE; NONHUMAN; PLACE PREFERENCE; RECEPTOR AFFINITY; RECEPTOR BLOCKING;

ANIMALIA;

EID: 0033548166     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(99)00036-3     Document Type: Article

References (20)

1. M. Watanabe, Y. Inoue, K. Sakimura and M. Mishina, NeuroReport 3 1138-1140 (1992)
2. K.A. Trujillo and H. Akill, Science 251 85-87 (1991)
3. A. Bespalov, M. Dumpis, L. Piotrovsky and E. Zvartau, Eur. J. Pharmacol. 264 233-239 (1994)
4. N.A. Rossi and L.D. Reid, Physiol. Psychol. 4 269-274 (1976)
5. E. Del Pozo, M. Barrios and J.M. Baeyens, Psychophamacology 125 209-213 (1996)
6. P. Popic and W. Danysz, J. Pharmacol. Exp. Ther. 280 854-865 (1996)
7. P. Avent, J. Léonardon, F. Besnard, D. Graham, J. Frost, H. Depoortere, S.Z. Langer and B. Scatton, Eur. J. Pharmacol. 296 209-213 (1996)
8. P. Avent, J. Léonardon, F. Besnard, D. Graham, H. Depoortere and B. Scatton, Neurosci. Lett. 223 133-136 (1997)
9. T. Suzuki, M. Funada, M. Narita, M. Misawa and H. Nagase, Brain Res. 602 45-52 (1993)
10. K. Kitaichi, Y. Noda, T. Hasegawa, H. Furukawa and T. Nabeshima, Eur. J. Pharmacol. 318 7-9 (1996)
11. A.M. Young and J.H. Woods, J. Pharmacol. Exp. Ther. 218 720-727 (1981)
12. D.R. Jasinski, E.J. Cone, C.W. Gorodetzky M.E. Risner, H.E. Shannon, T.P. Su and D.B. Vaupel, NIDA Res. Monogr. 27 61-69 (1979)
13. H. Kayama and P.R. Krishna, Anesthesiology 67 861-862 (1987)
14. W. Löscher, R. Annies and D. Hönack, Eur. J. Pharmacol. 242, 263-274 (1993)
15. G. Perrault, E. Morel, D.J. Sanger and B. Zivkovic, Br. J. Pharmacol. 97 580P (1989)
16. D.J. Sanger and D. Joly, Psychopharmacology 104 27-34 (1991)
17. M. Funada, T. Suzuki and M. Misawa, Ann. Psychiatry 5 223-237 (1995)
18. L. Pulvirenti, N.R. Swerdlow and G.F. Koob, Pharmacol. Biochem. Behav. 40 841-845 (1991)
19. P.W. Kalivas, Brain Res. Rev. 18 75-113 (1993)
20. D.G. Standaert, C.M. Testa, A.B. Young and J.B. Penney Jr., J. Comp. Neurol. 343 1-16(1994)